Case Study: Medically Compromised Patient — Type 2 Diabetes and Hypertension

Patient Snapshot

Patient: David Okonkwo, 58-year-old male Chief Complaint: "My gums bleed and my teeth feel different — like they don't fit together the same way anymore." ASA Classification: ASA III

Medical History

• Type 2 diabetes mellitus: Diagnosed 10 years ago. Most recent HbA1c (3 weeks ago): 8.4% (indicating poorly controlled diabetes; target for most adults is <7.0%)
• Hypertension: Diagnosed 8 years ago. Treated but not fully controlled; patient admits to occasionally missing doses of his antihypertensive medication
• Hyperlipidemia: Diagnosed 6 years ago
• No history of myocardial infarction, stroke, or transient ischemic attack
• No known cardiac valve abnormalities or murmurs
• No history of infective endocarditis
• Reports occasional episodes of hypoglycemia, usually mid-afternoon (described as shakiness, sweating, and confusion — resolves with eating)
• Reports increased thirst and urination over the past several months (polyuria and polydipsia — classic signs of hyperglycemia)

Medications

• Metformin 1,000 mg BID — for type 2 diabetes
• Glyburide 5 mg daily — sulfonylurea; stimulates insulin secretion (increases risk of hypoglycemia)
• Lisinopril 20 mg daily — ACE inhibitor for hypertension; also renoprotective in diabetes
• Hydrochlorothiazide (HCTZ) 25 mg daily — thiazide diuretic for hypertension (note: can cause xerostomia and may slightly elevate blood glucose)
• Atorvastatin 40 mg daily — for hyperlipidemia
• Aspirin 81 mg daily — for cardiovascular risk reduction (low-dose antiplatelet)

Allergies

• No known drug allergies
• No latex allergy

Vital Signs

• Blood pressure: 148/92 mmHg (right arm, seated, after 5 minutes rest) — confirmed on repeat measurement: 146/90 mmHg. This is consistent with Stage 1 hypertension (130–139/80–89) to Stage 2 hypertension (≥140/≥90) per AHA/ACC 2017 guidelines. Treatment modification needed.
• Heart rate: 84 bpm, regular
• Respiratory rate: 16 breaths/min
• Temperature: 98.6°F (37.0°C)

Clinical interpretation: The elevated blood pressure (148/92) is consistent with his stated history of medication non-adherence (occasionally missing lisinopril and HCTZ). His poorly controlled diabetes (HbA1c 8.4%) also contributes to hypertension through multiple mechanisms (sodium retention, increased vascular resistance, endothelial dysfunction). Elective dental treatment should NOT proceed without addressing these vitals.

Dental History

Mr. Okonkwo reports sporadic dental visits — approximately every 2–3 years — usually prompted by a problem rather than routine care. He brushes twice daily with a manual toothbrush and fluoridated toothpaste. He does not floss. He reports noticing increasing mobility of his lower anterior teeth over the past year. He has noticed that his gums bleed when he brushes, particularly in the past 6 months. He has no removable prostheses.

Periodontal Findings

Full-mouth charting reveals:

• Generalized probing depths: 4–7 mm; localized 8–9 mm pockets at teeth #14 (mesial), #19 (distal), and #30 (mesial)
• Clinical attachment loss: Generalized 3–6 mm; localized 7–8 mm at deepest sites
• Bleeding on probing: 58% of sites (significantly elevated)
• Furcation involvement: Class I buccal on #3 and #14; Class II buccal on #19 and #30
• Mobility: Class I mobility on teeth #23, #24, #25, #26 (mandibular anteriors)
• Recession: 1–3 mm generalized in posterior sextants; 2–4 mm on mandibular anteriors
• Suppuration: Present on probing at mesial of #14 and distal of #19
• AAP Classification: Stage III, Grade C periodontitis, generalized

Diabetes-periodontitis bidirectional relationship: Poorly controlled diabetes (HbA1c 8.4%) exacerbates periodontitis through formation of advanced glycation end-products (AGEs), impaired neutrophil function, hyperinflammatory response, and impaired wound healing. Conversely, the chronic inflammatory burden of periodontitis increases insulin resistance, making glycemic control MORE difficult. Treatment of periodontitis has been shown to reduce HbA1c by approximately 0.4–0.6% — a clinically meaningful improvement.

Radiographic Findings

• Generalized horizontal bone loss of 30–50%
• Vertical bone defects at mesial of #14, distal of #19, and mesial of #30
• Furcation radiolucency visible at #19 and #30
• Widened periodontal ligament at mandibular anteriors
• No caries detected
• No periapical pathology
• No significant calculus visible (most is subgingival)

Clinical Findings

• Generalized moderate to heavy supragingival and subgingival calculus
• Gingiva: Erythematous, edematous, with rolled margins and blunted papillae; tendency toward spontaneous bleeding in mandibular anterior sextant
• No active caries
• Xerostomia: Mild; attributed to HCTZ (thiazide diuretic) and possibly to poorly controlled hyperglycemia
• No oral mucosal lesions

Risk Assessment

Case Questions

Q1: Mr. Okonkwo's blood pressure is 148/92 mmHg. What is the appropriate action before proceeding with elective dental treatment?

Answer: Elective dental treatment should be deferred until the blood pressure is better controlled. The protocol: (1) Inform the patient of the elevated reading and its significance. (2) Recheck BP after 5–10 minutes of quiet rest — confirm the elevated reading (done: 146/90 on repeat). (3) Do NOT proceed with elective treatment — only emergency treatment (pain/infection control) should be performed. (4) Refer the patient back to his primary care physician or cardiologist for hypertension management; he has already admitted to missing doses, and his lisinopril/HCTZ regimen may need adjustment or reinforcement. (5) Document the reading, the decision to defer, and the referral. (6) Request medical clearance before rescheduling. The threshold for deferring elective treatment is generally systolic ≥160 mmHg and/or diastolic ≥100 mmHg (some guidelines use ≥180/≥110), but 148/92 in a patient with known but poorly controlled hypertension and admitted medication non-adherence warrants deferral and medical follow-up. Proceeding with treatment places the patient at risk for an acute hypertensive event (stroke, myocardial infarction) triggered by the stress of the dental appointment.

Q2: Mr. Okonkwo's HbA1c is 8.4%. What are the implications for his periodontal treatment, and what appointment modifications are indicated?

Answer: The HbA1c of 8.4% indicates poorly controlled diabetes with significant implications:

Implications for periodontal treatment:

• Impaired wound healing after scaling and root planing (delayed epithelial and connective tissue repair)
• Increased susceptibility to post-treatment infection
• Reduced treatment response — SRP outcomes are diminished in patients with HbA1c >7% compared to well-controlled patients
• The periodontal infection itself worsens insulin resistance; treating periodontitis is a therapeutic intervention that may help improve glycemic control

Appointment scheduling modifications:

1. Morning appointments (after breakfast): The patient should eat a normal meal and take his usual medications, including metformin and glyburide. Morning appointments minimize the risk of hypoglycemia during lengthy procedures.
2. Avoid peak insulin/sulfonylurea activity: Glyburide peaks at approximately 2–4 hours after dosing. Long afternoon appointments that extend into this window increase hypoglycemia risk.
3. Monitor for hypoglycemia signs: Shakiness, sweating, confusion, tachycardia. Keep a source of fast-acting glucose (glucose tablets, juice) available in the operatory.
4. Shorter appointments: Divide SRP into more quadrants over more visits to reduce stress and treatment burden.
5. Stress reduction protocol: Stress elevates blood glucose via catecholamine and cortisol release. Use profound local anesthesia, consider anxiolysis if indicated, and maintain a calm environment.
6. Post-operative instructions: Emphasize the importance of maintaining caloric intake after treatment; if the patient cannot eat due to anesthesia or discomfort, provide guidance on soft/liquid nutrition to avoid hypoglycemia.

Q3: Mr. Okonkwo suddenly becomes diaphoretic, tremulous, and confused 35 minutes into his SRP appointment. His blood glucose by glucometer reads 58 mg/dL. What is the appropriate emergency response?

Answer: This is hypoglycemia (blood glucose <70 mg/dL in a diabetic patient on sulfonylurea therapy). Emergency management: (1) Stop the procedure immediately. (2) If the patient is conscious and able to swallow safely, administer 15 grams of fast-acting oral carbohydrate: 4 glucose tablets (preferred), 4 oz fruit juice, or 4 oz regular (not diet) soda. (3) Recheck blood glucose in 15 minutes. If still <70 mg/dL, repeat the 15 g carbohydrate dose. (4) Once blood glucose normalizes and symptoms resolve, provide a snack with complex carbohydrates and protein to maintain blood glucose. (5) If the patient is unconscious or unable to swallow safely, do NOT give anything by mouth (aspiration risk). Administer 1 mg glucagon IM (or intranasal glucagon if available) and activate EMS (call 911). (6) Document the hypoglycemic event, treatment rendered, and blood glucose values. (7) Discontinue the dental appointment; the patient should not drive and should be monitored until fully recovered. (8) Notify the prescribing physician.

The root cause: Glyburide (sulfonylurea) stimulates endogenous insulin secretion regardless of blood glucose level. The stress of the appointment, possible reduced food intake that morning, and the duration of the procedure can all precipitate hypoglycemia.

Q4: How does Mr. Okonkwo's poorly controlled diabetes specifically impact his response to non-surgical periodontal therapy?

Answer: Poor glycemic control (HbA1c 8.4%) impacts periodontal therapy through multiple mechanisms:

1. Impaired neutrophil function: Hyperglycemia impairs neutrophil chemotaxis, adherence, phagocytosis, and intracellular killing. This means the host's first line of defense against periodontal pathogens is compromised, and the subgingival biofilm recolonizes more aggressively after SRP.
2. Hyperinflammatory state: AGEs (advanced glycation end-products) bind to RAGE receptors on macrophages and fibroblasts, triggering a sustained pro-inflammatory cytokine cascade (IL-1β, TNF-α, IL-6). This amplifies the tissue-destructive response to even modest bacterial challenge, meaning SRP alone may not adequately control inflammation.
3. Impaired collagen metabolism and wound healing: Hyperglycemia cross-links collagen, reducing its solubility and turnover. Post-SRP, the formation of new connective tissue attachment and the long junctional epithelium is slowed and compromised.
4. Microvascular changes: Thickening of the basement membrane in gingival capillaries impairs oxygen and nutrient delivery to healing tissues.
5. Reduced clinical outcomes: Systematic reviews demonstrate that patients with HbA1c >7% show significantly less probing depth reduction and CAL gain after SRP compared to well-controlled patients.

Clinical implication: Mr. Okonkwo should be informed that his periodontal treatment outcomes depend on glycemic control, and he should be strongly encouraged to work with his physician to bring HbA1c closer to the <7.0% target. Adjunctive therapies (local antimicrobial delivery, systemic antibiotics in selected cases, more frequent maintenance) may be considered given the reduced expected response.

Q5: Mr. Okonkwo's medication list includes lisinopril (ACE inhibitor), HCTZ (thiazide diuretic), aspirin, and metformin. Are there any drug interactions or side effects relevant to his dental care?

Answer: Yes — several clinically relevant considerations:

1. Lisinopril (ACE inhibitor): (a) Can cause angioedema (rare but potentially life-threatening swelling of lips, tongue, airway) — if this occurs, emergency management is indicated. (b) May cause orthostatic hypotension — raise the chair slowly after the appointment. (c) Concomitant use with NSAIDs (e.g., ibuprofen) can reduce the antihypertensive effect of ACE inhibitors and increase risk of renal impairment — avoid NSAIDs for post-operative pain. Use acetaminophen instead.

1. HCTZ (thiazide diuretic): (a) Contributes to xerostomia — already noted in the clinical findings. (b) May cause orthostatic hypotension combined with lisinopril. (c) Can cause electrolyte imbalances (hypokalemia, hyponatremia) — though not directly relevant to dental procedures, it indicates the patient's hypertension is being managed with a diuretic and may not be fully compensated.

1. Aspirin 81 mg (low-dose): Minimal effect on bleeding risk for nonsurgical periodontal therapy. No interruption needed. For surgical procedures (extractions, flap surgery), the risk is slightly elevated but most guidelines recommend continuing low-dose aspirin for cardiovascular protection — the risk of thrombotic event from discontinuation outweighs the risk of prolonged bleeding, which can be managed with local hemostatic measures.

1. Metformin: No direct dental implications. Rarely, metformin can cause a metallic taste. The main concern is that metformin is renally cleared; in patients with renal impairment, metformin accumulation can cause lactic acidosis (rare), but this is a medical management concern rather than a dental procedure concern.

1. NSAID avoidance: As noted, NSAIDs should generally be avoided in patients taking ACE inhibitors + diuretics (risk of reduced antihypertensive efficacy and renal impairment). Acetaminophen is the recommended analgesic.